Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

What Are Analysts Forecasting for Align Technology, Inc. (NASDAQ:ALGN) After Fresh Cuts?

● ALGN closed at $142.71 on 9 October 2026, and published averages of about $199 appear out of step with recent named targets of $155 to $209.

Nitish Kishor | 12 October 2026

Veraxa Biotech (NASDAQ:VRXA) Jumps as Small-Cap Biotech Names Catch a Bid

● VRXA closed Friday, October 9, 2026, at $1.300, up 19.27%, among the stronger small-cap biotechnology movers.

Nitish Kishor | 12 October 2026

XORTX Therapeutics (NASDAQ:XRTX) Falls Amid Biotech Micro-Cap Volatility

● XRTX closed Friday, October 9, 2026, at $1.410, down 23.78%, against a session in which healthcare was strong.

Nitish Kishor | 12 October 2026

YD Bio (NASDAQ:YDES) Advances in a Low-Float Micro-Cap Move

● YDES closed Friday, October 9, 2026, at $6.75, up 16.58%, among the day’s steeper micro-cap advancers.

Nitish Kishor | 12 October 2026

Why Did Quince Therapeutics (NASDAQ:QNCX) Shares Gain With the Small-Cap Biotech Group?

● QNCX closed Friday, October 9, 2026, at $34.69, up 18.15%, among the firmer small-cap biotechnology movers.

Nitish Kishor | 12 October 2026

Quantum-Si (NASDAQ:QSI) Stock: Low-Priced Life Sciences Tools Name Draws Buyers

● QSI closed Friday, October 9, 2026, at $1.600, up 31.15%, adding nearly a third to its prior value.

Nitish Kishor | 12 October 2026

Sunshine Biopharma (NASDAQ:SBFM) Slides in a Low-Volume Session With No Company News

● SBFM closed Friday, October 9, 2026, at $0.338, down 21.44%, ranking among the sharper decliners in the US session.

Nitish Kishor | 12 October 2026

Why Scienture Holdings (NASDAQ:SCNX) Is Drawing Investor Attention as Its Path to Profitability Takes Shape

● Net loss was $2.82 million, 58% narrower than the $6.72 million loss a year earlier.

Nitish Kishor | 12 October 2026

China SXT Pharmaceuticals (NASDAQ:SXTC) Collapses in Thin Sub-Dollar Trade

● SXTC closed Friday, October 9, 2026, at $0.149, down 56.71%, among the steepest decliners on the session.

Nitish Kishor | 12 October 2026

Spyre Therapeutics (NASDAQ:SYRE) Climbs With Healthcare Leading the Rebound

● Healthcare was one of the two leading sectors, advancing roughly 1.48% and trailing only Real Estate.

Nitish Kishor | 12 October 2026
Support

Hi! How can we help you today?

Loading…